Ross Osborn
Stock Analyst at Cantor Fitzgerald
(0)
# 4091
Out of 5,319 analysts
114
Total ratings
23.96%
Success rate
-10.36%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
NNOX Nano X Imaging | Maintains: Overweight | 12 9 | 5.2 | 73.08% | 11 | Apr 1, 2025 | |
SMTI Sanara MedTech | Reiterates: Overweight | 46 46 | 29.43 | 56.3% | 6 | Mar 26, 2025 | |
LUCD Lucid Diagnostics | Reiterates: Overweight | 2 2 | 1.21 | 65.29% | 5 | Mar 26, 2025 | |
ELUT Elutia | Reiterates: Overweight | 8 8 | 2.32 | 244.83% | 10 | Mar 7, 2025 | |
AXGN Axogen | Reiterates: Overweight | 24 24 | 15.57 | 54.14% | 3 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 19 20 | 10.79 | 85.36% | 5 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 13 | 6.68 | 94.61% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 25 25 | 13.85 | 80.51% | 8 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.3 | 207.69% | 4 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 9 9 | 4.01 | 124.44% | 7 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 8 8 | 4.49 | 78.17% | 5 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 2.88 | 212.5% | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 21 21 | 9.21 | 128.01% | 10 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 6.04 | 164.9% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 14 14 | 6.25 | 124% | 2 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 96 | 86.28 | 11.27% | 1 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 4 4 | 1.17 | 199.15% | 5 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 3 3 | 0.49 | 410.2% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 7 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 4 4 | 0.08 | 4025% | 5 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 4.22 | 18.48% | 2 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Nov 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 9 | 0.71 | 1112.68% | 2 | Aug 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 27 21 | n/a | n/a | 2 | Apr 22, 2022 |